Literature DB >> 11317214

Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly.

S Govoni1, M Racchi, E Masoero, M Zamboni, L Ferini-Strambi.   

Abstract

Depression is the most prevalent functional psychiatric disorder in late life. The problem of motor disorders associated with antidepressant use is relevant in the elderly. Elderly people are physically more frail and more likely to be suffering from physical illness, and any drug given may exacerbate pre-existing diseases, or interact with other drug treatments being administered for physical conditions. Antidepressants have been reported to induce extrapyramidal symptoms, including parkinsonism. These observations prompted us to review the neurobiological mechanism that may be involved in this complex interplay including neurotransmitters and neuronal circuits involved in movement and emotion control and their changes related to aging and disease. The study of the correlations between motor and mood disorders and their putative biochemical bases, as presented in this review, provide a rationale either to understand or to foresee motor side effects for psychotropic drugs, in particular antidepressants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317214     DOI: 10.1038/sj.mp.4000801

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  8 in total

1.  Prevalence of Potential Pharmacological Interactions in Patients Undergoing Systemic Chemotherapy in a Tertiary Hospital.

Authors:  Eric Diego Turossi-Amorim; Bruna Camargo; Fabiana Schuelter-Trevisol
Journal:  Hosp Pharm       Date:  2022-04-02

2.  Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.

Authors:  Samantha J Podurgiel; Meredith N Milligan; Samantha E Yohn; Laura J Purcell; Hector M Contreras-Mora; Mercè Correa; John D Salamone
Journal:  Neuropsychopharmacology       Date:  2015-03-11       Impact factor: 7.853

Review 3.  Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia.

Authors:  Viacheslav Terevnikov; Grigori Joffe; Jan-Henry Stenberg
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

4.  Internet-based cognitive behavioural therapy programme as an intervention for people diagnosed with adult-onset, focal, isolated, idiopathic cervical dystonia: a feasibility study protocol.

Authors:  Megan E Wadon; Mia Winter; Kathryn J Peall
Journal:  Pilot Feasibility Stud       Date:  2020-07-15

Review 5.  Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects.

Authors:  Yukihiro Ohno; Naofumi Kunisawa; Saki Shimizu
Journal:  Front Pharmacol       Date:  2019-09-17       Impact factor: 5.810

6.  Internet-based cognitive behavioural therapy as a feasible treatment of adult-onset, focal, isolated, idiopathic cervical dystonia.

Authors:  Megan E Wadon; Claire MacIver; Mia Winter; Kathryn J Peall
Journal:  Clin Park Relat Disord       Date:  2021-11-27

7.  Serotonin Syndrome Triggered by Overuse of Caffeine and Complicated With Neuroleptic Malignant Syndrome: A Case Report.

Authors:  Ryuichi Ohta; Chiaki Sano
Journal:  Cureus       Date:  2022-02-21

8.  Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia.

Authors:  Megan E Wadon; Grace A Bailey; Zehra Yilmaz; Emily Hubbard; Meshari AlSaeed; Amy Robinson; Duncan McLauchlan; Richard L Barbano; Laura Marsh; Stewart A Factor; Susan H Fox; Charles H Adler; Ramon L Rodriguez; Cynthia L Comella; Stephen G Reich; William L Severt; Christopher G Goetz; Joel S Perlmutter; Hyder A Jinnah; Katharine E Harding; Cynthia Sandor; Kathryn J Peall
Journal:  Brain Behav       Date:  2021-07-21       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.